Related Experiment Videos
Is sestamibi-guided parathyroidectomy really cost-effective?
A K Greene1, P Mowschenson, R A Hodin
1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, Mass. 02215, USA.
Surgery
|December 22, 1999
Summary
Sestamibi-guided parathyroidectomy may not be more cost-effective than standard bilateral neck exploration. Bilateral exploration offers a high success rate with minimal morbidity and excellent cosmetic results, often on an outpatient basis.
Area of Science:
- Endocrine Surgery
- Surgical Oncology
Background:
- Sestamibi-guided limited neck explorations are an alternative to standard bilateral neck exploration for primary hyperparathyroidism.
- A meta-analysis suggested sestamibi-directed surgery offers cost benefits.
- This study evaluates the cost-effectiveness of sestamibi-directed parathyroidectomy.
Purpose of the Study:
- To compare the cost-effectiveness of sestamibi-guided parathyroidectomy versus standard bilateral neck exploration.
- To evaluate the outcomes of bilateral neck exploration in primary hyperparathyroidism.
Main Methods:
- Review of 41 bilateral neck explorations for primary hyperparathyroidism.
- Comparison of institutional results with a published meta-analysis.
- Analysis of operative times, recovery room times, outpatient rates, and frozen sections.
Main Results:
- Standard bilateral exploration was 47% less costly than the bilateral approach and 17% less than the sestamibi-directed approach.
- High cure rate (98%) with no nerve injury or permanent hypocalcemia.
- 61% of patients did not require postoperative narcotics, with excellent cosmetic outcomes.
Conclusions:
- Sestamibi-guided parathyroidectomy may not offer advantages over standard bilateral exploration.
- Bilateral neck exploration can be performed cost-effectively on an outpatient basis with high success and low morbidity.
- Standard bilateral exploration provides excellent outcomes and patient satisfaction.